220 related articles for article (PubMed ID: 19195498)
1. Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event.
Rawlings R; Nohria A; Liu PY; Donnelly J; Creager MA; Ganz P; Selwyn A; Liao JK
Am J Cardiol; 2009 Feb; 103(4):437-41. PubMed ID: 19195498
[TBL] [Abstract][Full Text] [Related]
2. Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis.
Liu B; Zhang JY; Cao HM; Wang Q; Wang HB
Intern Med; 2012; 51(10):1177-82. PubMed ID: 22687786
[TBL] [Abstract][Full Text] [Related]
3. Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.
Liu B; Cao HM; Li GY; Liu M; Feng J; Li J; Wang Q
J Int Med Res; 2011; 39(6):2314-22. PubMed ID: 22289549
[TBL] [Abstract][Full Text] [Related]
4. Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial.
Insull W; Ghali JK; Hassman DR; Y As JW; Gandhi SK; Miller E;
Mayo Clin Proc; 2007 May; 82(5):543-50. PubMed ID: 17493418
[TBL] [Abstract][Full Text] [Related]
5. Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN.
Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
JACC Cardiovasc Imaging; 2014 Oct; 7(10):1013-22. PubMed ID: 25240453
[TBL] [Abstract][Full Text] [Related]
6. Superior benefit of aggressive lipid-lowering therapy for high- risk patients using statins: the SUBARU study--more hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin therapy.
Kurabayashi M; Yamazaki T;
J Atheroscler Thromb; 2008 Dec; 15(6):314-23. PubMed ID: 19060425
[TBL] [Abstract][Full Text] [Related]
7. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.
Ballantyne CM; Raichlen JS; Cain VA
J Am Coll Cardiol; 2008 Aug; 52(8):626-32. PubMed ID: 18702965
[TBL] [Abstract][Full Text] [Related]
8. Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.
Ai M; Otokozawa S; Asztalos BF; Nakajima K; Stein E; Jones PH; Schaefer EJ
Am J Cardiol; 2008 Feb; 101(3):315-8. PubMed ID: 18237592
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective.
Costa-Scharplatz M; Ramanathan K; Frial T; Beamer B; Gandhi S
Clin Ther; 2008 Jul; 30(7):1345-57. PubMed ID: 18691996
[TBL] [Abstract][Full Text] [Related]
10. Statins inhibit Rho kinase activity in patients with atherosclerosis.
Nohria A; Prsic A; Liu PY; Okamoto R; Creager MA; Selwyn A; Liao JK; Ganz P
Atherosclerosis; 2009 Aug; 205(2):517-21. PubMed ID: 19167712
[TBL] [Abstract][Full Text] [Related]
11. Decreasing LDL cholesterol and medication cost with every-other-day statin therapy.
Juszczyk MA; Seip RL; Thompson PD
Prev Cardiol; 2005; 8(4):197-9. PubMed ID: 16230873
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
Asztalos BF; Le Maulf F; Dallal GE; Stein E; Jones PH; Horvath KV; McTaggart F; Schaefer EJ
Am J Cardiol; 2007 Mar; 99(5):681-5. PubMed ID: 17317371
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER).
Nicholls SJ; Brandrup-Wognsen G; Palmer M; Barter PJ
Am J Cardiol; 2010 Jan; 105(1):69-76. PubMed ID: 20102893
[TBL] [Abstract][Full Text] [Related]
14. Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.
Davidson M; Ma P; Stein EA; Gotto AM; Raza A; Chitra R; Hutchinson H
Am J Cardiol; 2002 Feb; 89(3):268-75. PubMed ID: 11809427
[TBL] [Abstract][Full Text] [Related]
15. Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: an analysis from the VOYAGER database.
Palmer MK; Nicholls SJ; Lundman P; Barter PJ; Karlson BW
Eur J Prev Cardiol; 2013 Dec; 20(6):1080-7. PubMed ID: 23644489
[TBL] [Abstract][Full Text] [Related]
16. Statin wars: emphasis on potency vs event reduction and safety?
Lavie CJ; Milani RV; O'Keefe JH
Mayo Clin Proc; 2007 May; 82(5):539-42. PubMed ID: 17493417
[No Abstract] [Full Text] [Related]
17. Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia.
Park JS; Kim YJ; Choi JY; Kim YN; Hong TJ; Kim DS; Kim KY; Jeong MH; Chae JK; Oh SK; Seong IW
Korean J Intern Med; 2010 Mar; 25(1):27-35. PubMed ID: 20195400
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
Jones PH; Davidson MH; Stein EA; Bays HE; McKenney JM; Miller E; Cain VA; Blasetto JW;
Am J Cardiol; 2003 Jul; 92(2):152-60. PubMed ID: 12860216
[TBL] [Abstract][Full Text] [Related]
19. Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans.
Wouters CW; Wever KE; Bronckers I; Hopman MT; Smits P; Thijssen DH; Rongen GA
J Cardiovasc Pharmacol; 2012 Jan; 59(1):22-8. PubMed ID: 21885990
[TBL] [Abstract][Full Text] [Related]
20. Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation.
Thongtang N; Ai M; Otokozawa S; Himbergen TV; Asztalos BF; Nakajima K; Stein E; Jones PH; Schaefer EJ
Am J Cardiol; 2011 Feb; 107(3):387-92. PubMed ID: 21257003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
